References
Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;. doi:10.1001/jama.2011.1591.
Miettinen OS, Henschke CI, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? Lancet. 2002;359:404–6.
Chien CR, Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer. 2008;122:2594–9.
Wu D, Erwin D, Rosner GL. Sojourn time and lead time projection in lung cancer screening. Lung Cancer. 2011;72:322–6.
Sagawa M, Nakayama T, Tsukada H, et al. The efficacy of lung cancer screening conducted in 1990s: 4 case–control studies in Japan. Lung Cancer. 2003;41:29–36.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
The JECS Study Group—Japanese randomized trial for evaluating the efficacy of low-dose thoracic CT screening for lung cancer in never or light smokers, PI: Motoyasu Sagawa, MD.
Rights and permissions
About this article
Cite this article
Sagawa, M., Nakayama, T., Sobue, T. et al. A different interpretation of the efficacy of lung cancer screening in the PLCO trial. Eur J Epidemiol 31, 211–212 (2016). https://doi.org/10.1007/s10654-015-0070-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-015-0070-1